Guidelines for the Investigation of Hypoglycaemia

 

Reviewed by Jane Harding
January
2001
Clinical Guidelines Back Newborn Services Home Page

See guideline on management of hypoglycaemia

Persistent or severe hypoglycaemia (requiring more than 10mg/kg/min of glucose or lasting longer than 1 week) may require further investigation and management, e.g. with glucagon, diazoxide, steroids or surgery.  Consider discussing with Paediatric Endocrine Service.

In an emergency, particularly if there is difficulty in starting intravenous glucose infusion, glucagon 100 to 300μg/kg intramuscularly will stabilise blood glucose in most babies for one to two hours. The dose can be repeated, but subsequent doses are much less likely to be effective. (Glucagon mobilises glycogen stores. After the first dose, stores will probably be depleted).

Symptoms

  • Abnormal cry
  • Lethargy, apathy, floppiness (hypotonia)
  • Poor feeding
  • Jitteriness
  • Apnoea
  • Convulsions
  • Signs of neuroglycopaenia

 Other signs occur occasionally:

  • Pallor
  • Sweating
  • Tachycardia
  • Due to catecholamine response
    • Unusual in neonates except those with hyperinsulinaemia
  • Bradycardia
  • Hypotension
  • Heart failure
  • Cardiac arrest
  • Effect of hypoglycaemia on heart
    • Common following severe asphyxia.

Causes of Hypoglycaemia

  1. Transient neonatal hypoglycaemia.
  2. Hyperinsulinism
  3. Endocrine Causes
  4. Inborn Errors of Metabolism
  5. Other Problems

Investigations for Hypoglycaemia

At the time of low blood glucose (i.e. measure the glucose at the same time):

  • Insulin     
200μl in plain (red) top tube  2 x plain micro-containers
  • Cortisol
200μl in plain (red) top tube
  • Growth Hormone
100μl in plain (red) top tube
  • Ketones
50μl in plain (red) top tube 
  • Free fatty acids
1ml blood in EDTA tube, sent to the laboratory on ice (is analysed in Christchurch)

Can Be Done at Any Time:

  • Ammonia
2ml blood in green top (heparinised) tube on ice and prior warning of laboratory

References

1 Koh THHG, Aynsley-Green A, Tarbit M, Eyre JA; Neural dysfunction during hypoglycaemia.  Arch Dis Child 1988; 63: 1353-1358.
2 Koh THHG, Eyre JA, Aynsley-Green A; Neonatal hypoglycaemia - the controversy regarding definition.  Arch Dis Child 1988; 63:1386-1398
3 LaFranchi S; Hypoglycaemia of infancy and childhood. Pediatric Clin N Amer 1987; 34(4): 961-80.
4 Lubchenco LO, Bard H; Incidence of hypoglycemia in newborn infants classified by birth weight and gestational age.  Pediatrics 1971; 47: 831-8.
5 Lucas A, Morley R, Cole TJ; Adverse neurodevelopmental outcome of moderate neonatal hypoglycaemia.  Br Med J 1971; 297: 1304-8.
6 Senior B, Sadeghi-Nejad A; Hypoglycemia: A pathophysiologic approach.  Acta Paediatr Scand Suppl 1989; 352: 1-27.
7 Glaser B, Thornton P, Otonkoski T, Junien C.  Genetics of neonatal hyperinsulinism.  Arch Dis Child Fetal Neonatal Ed 2000; 82:F79-F86.
8 Shepherd RM, Cosgrove KE, O'Brien RE, et al.  Hyperinsulinism of infancy: towards an understanding of unregulated insulin release.  Arch Dis Child Fetal Neonatal Ed 2000; 82:F87-F97.
9 Aynsley-Green A, Hussain K, Hall J, et al.  Practical management of hyperinsulinism in infancy.  Arch Dis Child Fetal Neonatal Ed 2000; 82:F98-F107.
10 Rahier J, Guiot Y, Sempoux C.  Persistent hyperinsulinaemic hypoglycaemia of infancy: a heterogenous syndrome unrelated to nesidioblastosis.  Arch Dis Child Fetal Neonatal Ed 2000; 82:F108-F112.